GILEAD SCIENCES, INC. - Common Stock (GILD)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Number of holders
1,666
Total 13F shares, excl. options
1,032,141,981
Shares change
-3,619,120
Total reported value, excl. options
$70,791,566,038
Value change
-$264,255,142
Put/Call ratio
76%
Number of buys
743
Number of sells
-835
Price
$68.61

Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2024

1,896 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2024.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,666 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,032,141,981 shares of 1,240,722,841 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (120,632,023 shares), VANGUARD GROUP INC (115,261,774 shares), Capital World Investors (76,249,819 shares), Capital Research Global Investors (60,427,714 shares), STATE STREET CORP (59,329,915 shares), Dodge & Cox (33,122,337 shares), GEODE CAPITAL MANAGEMENT, LLC (26,966,449 shares), WELLINGTON MANAGEMENT GROUP LLP (22,935,083 shares), MORGAN STANLEY (19,337,304 shares), and FMR LLC (18,482,158 shares).
This table shows the top 1,666 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.